Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Eisai reports positive data from Phase Ib/II study of lenvatinib for RCC

Go Top